We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
RE/MAX Holdings
RMAX
$211M
| $334K | ﹤0.01% |
38,136
-78,411
| -67% | -$756K |
|
|
ALIM
2052
DELISTED
Alimera Sciences
ALIM
| $333K | ﹤0.01% |
+85,301
| New | +$325K |
|
2053
International General Insurance
IGIC
$1.24B
| $332K | ﹤0.01% |
24,499
-17,086
| -41% | -$223K |
|
|
FFNW
2054
DELISTED
First Financial Northwest, Inc
FFNW
| $327K | ﹤0.01% |
+15,925
| New | +$317K |
|
2055
Alto Neuroscience
ANRO
$1.07B
| $327K | ﹤0.01% |
+21,293
| New | +$333K |
|
|
TE
2056
T1 Energy
TE
$1.16B
| $327K | ﹤0.01% |
+194,461
| New | +$308K |
|
2057
ReposiTrak
TRAK
$156M
| $326K | ﹤0.01% |
+20,586
| New | +$270K |
|
|
RWT
2058
Redwood Trust
RWT
$584M
| $325K | ﹤0.01% |
+50,984
| New | +$333K |
|
|
AERTW
2059
CALL
Aeries Technology Warrant
AERTW
| $324K | ﹤0.01% |
165,381
| – | – |
|
2060
Brixmor Property Group
BRX
$9.9B
| $324K | ﹤0.01% |
+13,797
| New | +$313K |
|
2061
Tyra Biosciences
TYRA
$1.83B
| $322K | ﹤0.01% |
19,643
-10,358
| -35% | -$170K |
|
|
PLGO
2062
Pelagos Insurance Capital
PLGO
$2.23B
| $322K | ﹤0.01% |
16,519
+1,805
| +12% | +$26.6K |
|
2063
Tactile Systems Technology
TCMD
$635M
| $322K | ﹤0.01% |
19,800
-45,152
| -70% | -$682K |
|
|
CNSL
2064
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $321K | ﹤0.01% |
74,200
| – | – |
|
2065
SLM Corp
SLM
$4.74B
| $320K | ﹤0.01% |
+14,700
| New | +$293K |
|
|
TARO
2066
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $318K | ﹤0.01% |
+7,500
| New | +$316K |
|
2067
Metallus
MTUS
$885M
| $316K | ﹤0.01% |
14,192
-4,663
| -25% | -$97.2K |
|
2068
INmune Bio
INMB
$46M
| $315K | ﹤0.01% |
+26,825
| New | +$324K |
|
2069
Identive
INVE
$64.3M
| $314K | ﹤0.01% |
39,709
-8,940
| -18% | -$71.3K |
|
2070
Personalis
PSNL
$1.28B
| $314K | ﹤0.01% |
210,902
+59,221
| +39% | +$91.7K |
|
2071
Intercorp Financial Services
IFS
$6.53B
| $312K | ﹤0.01% |
+13,100
| New | +$331K |
|
2072
PUT
Chevron
CVX
$373B
| $311K | ﹤0.01% |
1,900
-57,200
| -97% | -$8.63M |
|
|
ATYR
2073
aTyr Pharma
ATYR
$46.2M
| $309K | ﹤0.01% |
+158,619
| New | +$277K |
|
2074
Tonix Pharmaceuticals
TNXP
$166M
| $309K | ﹤0.01% |
509
-241
| -32% | -$260K |
|
2075
Cadeler
CDLR
$2.09B
| $309K | ﹤0.01% |
+17,039
| New | +$300K |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.